11β-Hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects

Steroids

Volumn 61, Issue 4, 1996, Pages 263-269

  Edwards, Christopher R W ^a   Benediktsson, Rafn ^b   Lindsay, Robbie S ^b   Seckl, Jonathan R ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glucocorticoid; Hypertension; Mineralocorticoid; Programming

Indexed keywords

ANIMALIA; GLYCYRRHIZA;

11BETA HYDROXYSTEROID DEHYDROGENASE; DEXAMETHASONE; GLUCOCORTICOID; MINERALOCORTICOID RECEPTOR;

CONFERENCE PAPER; CORTICOSTEROID METABOLISM; ENZYME DEFICIENCY; ENZYME INHIBITION; GENE MUTATION; HORMONE ACTION; LOW BIRTH WEIGHT; PLACENTA WEIGHT; PROTEIN RESTRICTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; BIRTH WEIGHT; BLOOD PRESSURE; CORONARY DISEASE; DIET; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; INFANT; INFANT MORTALITY; ORGAN SIZE; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SYNDROME;

EID: 0029916575     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0039-128X(96)00033-5     Document Type: Article

References (68)

1. Lakshmi V, Monder C (1988). Purification and characterisation of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390-2398.
2. Agarwal AK, Monder C, Eckstein B, White PC (1989). Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 264:18939-18943.
3. Low SC, Chapman KE, Edwards CRW, Seekl JR (1994). Liver-type 11β-hydroxysteroid dehydrogenase cDNA encodes reductase not dehydrogenase activity in intact mammalian COS-7 cells. J Mol Endocrinol 13:167-174.
4. Seckl JR (1993) 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 23:589-601.
5. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C (1988). Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocortiroid receptor. Lancet ii:986-989.
6. Rundle C, Funder J, Lakshmi V, Monder C (1989). The intrarenal localization of mineralocorticoid receptors and 11β-dehydrogenase: immunocytochemical studies. Endocrinology 125:1700-1704.
7. Brown RW, Chapman KE, Edwards CRW, Seckl JR (1993). Human placental 11β-hydroxysteroid dehydrogenase: partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinology 132:2614-2621.
8. Stewart PM, Rogerson FM, Mason JI (1995). Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J Clin Endocrinol Metab 80:885-890.
9. Baggia S, Albrecht E, Pepe G (1990). Regulation of 11β-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen. Endocrinology 126:2742-2748.
10. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CRW, Seckl JR (1993). Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 139:27-35.
11. Duperrex H, Kenouch S, Gaeggeler H-P, Seckl JR, Edwards CRW, Farman N, Rossier BC (1993). Rat liver 11β-hydroxysteroid dehydrogenase cDNA encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology 132:612-619.
12. Nikkilä H, Tannin GM, Taylor NF, Kalaitzoglou G, Monder C, White PC (1993). Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. Endocr. Soc. Abstr. 75:153 (Abstr. 410)
13. Rusvai E, Náray-Fejes-Tóth A (1993). A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 268:10717-10720.
14. Brown RW, Chapman KE, Edwards CRW, Seckl JR (1994). Isolation of 11β-hydroxysteroid dehydrogenase type 2. J. Endocrinol 140 (suppl.):OC34.
15. Monder C, Lakshmi V (1990). Corticosteroid 11β-dehydrogenase of rat tissues: immunological studies. Endocrinology 126:2435-2443.
16. Brown RW, Chapman KE, Kotolevtsev Y, Yau JLW, Leckie C, Murad P, Lyons V, Edwards CRW, Seckl JR (1995). Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. J Endocrinol. 144 (suppl.):OC35.
17. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994). Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105:R11-R17.
18. Pawlowski JE, Huizinger M, Penning TM (1991). J Biol Chem 266:8820-8825.
19. Zhao HF, Labrie C, Simard J, De Launoit Y, Trudel C, Martel C, Rheaume E, Dupont E, Luu-The V, Pelletier G, Labrie F (1991). Characterization of the 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase cDNAs and differential tissue expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J Biol Chem 266:583-593.
20. Cheng K-C, White PC, Qin K-N (1991). Molecular cloning and expression of rat liver 3α-hydroxysteroid dehydrogenase. Mol Endocrinol 5:823-828.
21. Naville D, Keeney DS, Jenkin G, Murry BA, Head JR, Mason JI (1991). Regulation of expression of male-specific rat liver microsomal 3β-hydroxysteroid dehydrogenase. Mol Endocrinol 5:1090-1100.
22. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ (1993). Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol 77:1174-1179.
23. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW (1992). Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol 37:483-492.
24. Edwards CRW, Benediktsson R, Lindsay R, Seckl JR (1993). Dysfunction of the placental glucocorticoid barrier: a link between the fetal environment and adult hypertension: Lancet 341:355-357.
25. Seckl JR (1994). Glucocorticoids and small babies. Quart J Med 87:259-262.
26. Barker DJP, Osmond C (1986). Infant mortality, childhood nutrition and ischaemic heart disease in England and Wales. Lancet i:1077-1081.
27. Forsdahl A (1977). Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med 31:91-95.
28. Wadsworth MEJ, Cripps HA, Midwinter RE, Colley JRT (1985). Blood pressure in a national birth cohort, at the age of 36 related to social and familial factors, smoking, and body mass. Br Med J 291:1534-1538.
29. Barker DJP, Bull AR, Osmond C, Simmonds SJ (1990). Fetal and placental size and risk of hypertension in adult life. Br Med J 301: 259-263.
30. Barker DJP, Osmond C, Goldings J, Kuh D, Wadsworth MEJ (1989). Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br Med J 298:564-567.
31. Law CM, de Swiet M, Osmond C, Fayers PM, Barker DJP, Crudas AM, Fall CHD (1993). Initiation of hypertension in utero and its amplification throughout life. Br Med J 306:24-27.
32. Whincup PH, Cook DG, Shaper AG (1989). Early influences on blood pressure: a study of children aged 5-7 years. Br Med J 299: 587-591.
33. Law CM, Barker DJP, Bull AR, Osmond C (1991). Maternal and fetal influences on blood pressure. Arch Dis Child 66:1291-1295.
34. Levy L, Jackson AA (1993). Modest restriction of dietary protein during pregnancy in the rat: fetal and placental growth. J Dev Physiol 19:113-118.
35. Langley SC, Jackson AA (1994). Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci 86:217-222.
36. Godfrey KM, Redman CWG, Barker DJP, Osmond C (1991). The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight. Br J Obstet Gynaecol 98:886-891.
37. Godfrey KM, Forrester T, Barker DJP, et al. (1994). Maternal nutritional status in pregnancy and blood pressure in childhood. Br J Obstet Gynaecol 101:398-403.
38. Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW (1993). Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet 341:339-341.
39. Benediktsson R, Noble J, Calder AA,W ECR, Seckl JR (1995). 11β-Hydroxysteroid dehydrogenase activity in intact dually perfused fresh human placenta predicts birth weight. J Endocrinol 144 (suppl.):161.
40. Gunberg DL (1957). Some effects of exogenous hydrocortisone on pregnancy in the rat. Anat Res 129:133-153.
41. Reinisch JM, Simon NG, Karwo WG, et al (1978). Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science 202:436-438.
42. Benediktsson R, Brennand J, Tibi L, Calder AA, Seekl JR, Edwards CRW (1995). Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol 42:551-555.
43. Siebe H, Baude G, Lichtenstein I, Wang D, Buhler H, Hoyer GA, Hierholzer K (1993). Metabolism of dexamethasone: sites and activity in mammalian tissues. Renal Physiol Biochem 16:79-88.
44. Lindsay RS, Noble JM, Edwards CRW, Seckl JR (1994). Maternal carbenoxolone treatment reduces birth weight in the rat. J Endocrinol 140 (suppl.):18.
45. Phillips GJ, Langley-Evans SC, Benediktsson R, Seckl JR, Edwards CRW, Jackson AA (1994). The role of dietary protein restriction during pregnancy on the activity of placental 11β-hydroxysteroid dehydrogenase. Proc Nutr Soc 53:170A.
46. Baker M (1996). Unusual evolution of the 17β- and 11β-hydroxysteroid dehydrogenases. Bioessays (in press).
47. Gaeggeler H-P, Edwards C, Rossier B (1989). Steroid metabolism determines mineralocorticoid specificity in the toad bladder. Am J Physiol. 257:F690-F695.
48. Brem A, Matheson K, Latif S, Morris D (1993). Activity of 11β-hydroxysteroid dehydrogenase in toad bladder: effects of 11-dehydrocorticosterone. Am J Physiol 264:F854-F858.
49. Funder JW, Pearce PT, Smith R, Smith AI (1988). Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585.
50. Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW (1987). Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii: 821-824.
51. Stewart PM, Corrie JET, Shackleton CHL, Edwards CW (1988). Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 82:340-349.
52. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC (1995). Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet 10:394-399.
53. Stewart P, Krozowski Z, Gupta A, Milford D, Howie A, Sheppard M, Whorwood C (1996). Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:88-91.
54. Langley-Evans SC, Phillips GJ, Jackson AA (1995). Pharmacological adrenalectomy during pregnancy abolishes maternal diet-induced hypertension in the rat. Proc Nutr Soc (in press).
55. Slotkin TA, Seidler FJ, Kavlock RJ, Gray JA (1992). Fetal dexamethasone exposure accelerates development of renal function: relationship to dose, cell differentiation and growth inhibition. J Dev Physiol 17:55-61.
56. LaBorde JB, Hansen DK, Young JF, Sheehan DM, Holson RR (1992). Prenatal dexamethasone exposure in rats: effects of dose, age at exposure, and drug-induced hypophagia on malformations and fetal organ weights. Fund Appl Toxicol 19:545-554.
57. Fowden AL, Mijovc J, Silver M (1992). The effect of cortisol on hepatic and renal gluconeogenic enzyme activities in the sheep fetus during late gestation. J Endocrinol 137:213-222.
58. Gustafsson JA, Stenberg A (1974). Irreversible androgenic programming at birth of microsomal and soluble rat liver enzymes active on 4-androstene-3,17-dione and 5-α-androstane-3-α,17-β-diol. J Biol Chem 249:711-718.
59. Harris GW (1964). Sex hormones, brain development and brain function. Endocrinology 75:627-648.
60. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM (1988). Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 239:766-768.
61. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S (1994). Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol 6:341-345.
62. Levine S (1962). Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 135:795-796.
63. Levitt N, Lindsay RS, Holmes MC, Seckl JR (1995). Prenatal dexamethasone programs attenuated hippocampal glucocorticoid receptor gene expression and elevated basal corticosterone levels in adult life. Am Endocr Soc Abstr (in press).
64. Lever AF, Harrap SB (1992). Essential hypertension: a disorder of growth with origins in childhood? J Hypertension 10:101-120.
65. Bassett NS, Oliver MH, Breier BH, Gluckman PD (1990). The effect of maternal starvation on plasma insulin-like growth factor 1 concentrations in the late gestation ovine fetus. Paediatr Res 27: 401-404.
66. Jones JI, Clemmons DR (1995). Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34.
67. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD (1991). Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 303:1019-1022.
68. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clarke PMS (1993). Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36:62-67.